Scully R, Puget N, Vlasakova K
Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA.
Oncogene. 2000 Dec 11;19(53):6176-83. doi: 10.1038/sj.onc.1203971.
Heritable predisposition to breast and/or ovarian cancer is determined, in part, by germline mutation affecting one of two tumor suppressor genes, BRCA1 and BRCA2 (Miki et al., 1994; Wooster et al., 1995). These genes are required for the maintenance of genomic integrity and for control of homologous recombination in somatic and meiotic cells. Here, we explore the hypothesis that a major role of the BRCA gene products in the somatic DNA damage response centers upon the control of recombination between sister chromatids during S phase. By analogy with model organisms, we suggest that stalling of a mammalian DNA polymerase complex by its encounter with abnormal DNA structure calls forth a series of responses that collaborate to enforce appropriate recombinational outcomes, and to suppress inappropriate or 'illegitimate' recombination.
遗传性乳腺癌和/或卵巢癌易感性部分由影响两个肿瘤抑制基因BRCA1和BRCA2之一的种系突变决定(Miki等人,1994年;Wooster等人,1995年)。这些基因对于维持基因组完整性以及控制体细胞和减数分裂细胞中的同源重组是必需的。在这里,我们探讨了这样一种假说,即BRCA基因产物在体细胞DNA损伤反应中的主要作用集中在S期姐妹染色单体之间重组的控制上。通过与模式生物类比,我们认为哺乳动物DNA聚合酶复合物遇到异常DNA结构时的停滞引发了一系列协同作用的反应,以确保适当的重组结果,并抑制不适当或“非法”的重组。